pubmed-article:19836338 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:19836338 | lifeskim:mentions | umls-concept:C0037083 | lld:lifeskim |
pubmed-article:19836338 | lifeskim:mentions | umls-concept:C1136111 | lld:lifeskim |
pubmed-article:19836338 | lifeskim:mentions | umls-concept:C1333338 | lld:lifeskim |
pubmed-article:19836338 | lifeskim:mentions | umls-concept:C1710082 | lld:lifeskim |
pubmed-article:19836338 | lifeskim:mentions | umls-concept:C1323366 | lld:lifeskim |
pubmed-article:19836338 | lifeskim:mentions | umls-concept:C0678558 | lld:lifeskim |
pubmed-article:19836338 | lifeskim:mentions | umls-concept:C0678594 | lld:lifeskim |
pubmed-article:19836338 | pubmed:issue | 10 | lld:pubmed |
pubmed-article:19836338 | pubmed:dateCreated | 2009-10-19 | lld:pubmed |
pubmed-article:19836338 | pubmed:databankReference | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19836338 | pubmed:databankReference | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19836338 | pubmed:databankReference | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19836338 | pubmed:abstractText | The EphA4 tyrosine kinase cell surface receptor regulates an array of physiological processes and is the only currently known class A Eph receptor that binds both A and B class ephrins with high affinity. We have solved the crystal structure of the EphA4 ligand binding domain alone and in complex with (1) ephrinB2 and (2) ephrinA2. This set of structures shows that EphA4 has significant conformational plasticity in its ligand binding face. In vitro binding data demonstrate that it has a higher affinity for class A than class B ligands. Structural analyses, drawing on previously reported Eph receptor structures, show that EphA4 in isolation and in complex with ephrinA2 resembles other class A Eph receptors but on binding ephrinB2 assumes structural hallmarks of the class B Eph receptors. This interactive plasticity reveals EphA4 as a structural chameleon, able to adopt both A and B class Eph receptor conformations, and thus provides a molecular basis for EphA-type cross-class reactivity. | lld:pubmed |
pubmed-article:19836338 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19836338 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19836338 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19836338 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19836338 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19836338 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19836338 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19836338 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19836338 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19836338 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19836338 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19836338 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19836338 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19836338 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19836338 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19836338 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19836338 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19836338 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19836338 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19836338 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19836338 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19836338 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19836338 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19836338 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19836338 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19836338 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19836338 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19836338 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19836338 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19836338 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19836338 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19836338 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19836338 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19836338 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19836338 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19836338 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19836338 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19836338 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19836338 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19836338 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19836338 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19836338 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19836338 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19836338 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19836338 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19836338 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19836338 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19836338 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19836338 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19836338 | pubmed:language | eng | lld:pubmed |
pubmed-article:19836338 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19836338 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:19836338 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19836338 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19836338 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19836338 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:19836338 | pubmed:month | Oct | lld:pubmed |
pubmed-article:19836338 | pubmed:issn | 1878-4186 | lld:pubmed |
pubmed-article:19836338 | pubmed:author | pubmed-author:SieboldChrist... | lld:pubmed |
pubmed-article:19836338 | pubmed:author | pubmed-author:StuartDavid... | lld:pubmed |
pubmed-article:19836338 | pubmed:author | pubmed-author:JonesE... | lld:pubmed |
pubmed-article:19836338 | pubmed:author | pubmed-author:AricescuA... | lld:pubmed |
pubmed-article:19836338 | pubmed:author | pubmed-author:NettleshipJoa... | lld:pubmed |
pubmed-article:19836338 | pubmed:author | pubmed-author:BowdenThomas... | lld:pubmed |
pubmed-article:19836338 | pubmed:author | pubmed-author:OwensRaymond... | lld:pubmed |
pubmed-article:19836338 | pubmed:author | pubmed-author:Rahman-HuqNah... | lld:pubmed |
pubmed-article:19836338 | pubmed:issnType | Electronic | lld:pubmed |
pubmed-article:19836338 | pubmed:day | 14 | lld:pubmed |
pubmed-article:19836338 | pubmed:volume | 17 | lld:pubmed |
pubmed-article:19836338 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:19836338 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:19836338 | pubmed:pagination | 1386-97 | lld:pubmed |
pubmed-article:19836338 | pubmed:dateRevised | 2010-9-28 | lld:pubmed |
pubmed-article:19836338 | pubmed:meshHeading | pubmed-meshheading:19836338... | lld:pubmed |
pubmed-article:19836338 | pubmed:meshHeading | pubmed-meshheading:19836338... | lld:pubmed |
pubmed-article:19836338 | pubmed:meshHeading | pubmed-meshheading:19836338... | lld:pubmed |
pubmed-article:19836338 | pubmed:meshHeading | pubmed-meshheading:19836338... | lld:pubmed |
pubmed-article:19836338 | pubmed:meshHeading | pubmed-meshheading:19836338... | lld:pubmed |
pubmed-article:19836338 | pubmed:meshHeading | pubmed-meshheading:19836338... | lld:pubmed |
pubmed-article:19836338 | pubmed:meshHeading | pubmed-meshheading:19836338... | lld:pubmed |
pubmed-article:19836338 | pubmed:meshHeading | pubmed-meshheading:19836338... | lld:pubmed |
pubmed-article:19836338 | pubmed:meshHeading | pubmed-meshheading:19836338... | lld:pubmed |
pubmed-article:19836338 | pubmed:meshHeading | pubmed-meshheading:19836338... | lld:pubmed |
pubmed-article:19836338 | pubmed:meshHeading | pubmed-meshheading:19836338... | lld:pubmed |
pubmed-article:19836338 | pubmed:year | 2009 | lld:pubmed |
pubmed-article:19836338 | pubmed:articleTitle | Structural plasticity of eph receptor A4 facilitates cross-class ephrin signaling. | lld:pubmed |